INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples